Published in Drug Week, August 6th, 2004
"Although it is clear that TOR controls initiation of protein translation, recent results indicate that TOR is a central controller, integrating a plethora of signaling pathways that respond to growth factors and nutritional status," noted M.A. Bjornsti and colleagues at St. Jude Children's Hospital in Memphis.
"In addition to the role of rapamycin as an immune suppressant, emerging...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.